Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis.

European journal of human genetics : EJHG - 1 Mar 2010

Yu Ke, Zhang Jing, Zhang Jiyuan, Dou Chao, Gu Shaohua, Xie Yi, Mao Yumin, Ji Chaoneng

Abstract excerpt

Polymorphisms in methionine synthase (MTR) gene may be involved in carcinogenesis by affecting DNA methylation. However, association studies on MTR A2756G polymorphism in cancers have reported conflicting results. Therefore we performed a meta-analysis to better assess the associations. A total of 24 896 cancer patients and 33 862 controls from 52 articles for MTR A2756G were investigated. Overall, individuals...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asian People

Share to Europe

Share to Genetic Heterogeneity

Share to Neoplasms

Share to Odds Ratio

Share to Publication Bias

Source

Open in PubMed Open full text

Identifiers

PMID: 19826453
DOI: 10.1038/ejhg.2009.131
PMCID: PMC2987221

Genes

MTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis.PMID 19826453Read ↗

Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and breast cancer risk: an up-to-date meta-analysis.Semantic proximity Read ↗

Association between MTR A2756G polymorphism and childhood acute lymphoblastic leukemia: a meta-analysis.Semantic proximity Read ↗

The association between methionine synthase A2756G polymorphism and hematological cancer: A meta-analysis.Semantic proximity Read ↗

Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case-control studies.Semantic proximity Read ↗

Association between the MTHFR A1298C polymorphism and risk of cancer: evidence from 265 case-control studies.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies.Semantic proximity Read ↗

Methionine synthase reductase A66G polymorphism and leukemia risk: evidence from published studies.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and lymphoma risk: a meta-analysis.Semantic proximity Read ↗

Lack of association between methionine synthase A2756G polymorphism and digestive system cancer risk: evidence from 3,9327 subjects.Semantic proximity Read ↗

MTRR A66G polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.